Outcome: Dismissed
MAY022024_07B5203
Our summary
A pharmaceutical chemist self-petitioner sought EB-2 national interest waiver for a pharmacotherapeutic monitoring endeavor. The AAO dismissed the appeal, finding substantial merit but no national importance: evidence did not show how the proposed work would extend beyond direct patients to impact the field or have prospective broader implications.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
No criterion in the table was found met in this decision.
What was missing
- Merit and national importance · Pharmacotherapeutic monitoring program for vaccine-related blood clots lacked evidence of impact beyond individual patients; no broader field implications shown
Criteria
| Criterion | Reading | Why |
|---|---|---|
| Not met | Pharmacotherapeutic monitoring program for vaccine-related blood clots lacked evidence of impact beyond individual patients; no broader field implications shown | |
| Not reached / not discussed | Not analyzed; first prong failure made further prongs unnecessary | |
| Not reached / not discussed | Not analyzed; first prong failure made further prongs unnecessary |
A published decision describes one case. It is not legal advice and not a prediction for yours.
